Anti-FLT3 antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 6, 2011
Grant Date -
Jan 13, 2011
app pub date -
Sep 27, 2010
filing date -
May 30, 2008
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. The invention further provides methods of treating leukemia by administering an effective amount of an antibody either alone or in combination with an anti-cancer agent or treatment including methotrexate.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully